These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

261 related items for PubMed ID: 20395161

  • 21. Molecular and cellular interactions of HIV-1/HTLV coinfection and impact on AIDS progression.
    Casoli C, Pilotti E, Bertazzoni U.
    AIDS Rev; 2007; 9(3):140-9. PubMed ID: 17982939
    [Abstract] [Full Text] [Related]

  • 22. Macrophage-activating cytokines in human immununodeficiency virus type 1-infected and -uninfected patients with pulmonary tuberculosis.
    Mayanja-Kizza H, Johnson JL, Hirsch CS, Peters P, Surewicz K, Wu M, Nalugwa G, Mubiru F, Luzze H, Wajja A, Aung H, Ellner JJ, Whalen C, Toossi Z.
    J Infect Dis; 2001 Jun 15; 183(12):1805-9. PubMed ID: 11372035
    [Abstract] [Full Text] [Related]

  • 23. T-lymphocytopaenia, opportunistic infections and pathological findings in Ghanaian AIDS patients and their sexual partners.
    Ayisi NK, Wiredu EK, Sata T, Nyadedzor C, Tsiagbe VK, Newman M, Cofie CN, Taneguchi K.
    East Afr Med J; 1997 Dec 15; 74(12):784-91. PubMed ID: 9557423
    [Abstract] [Full Text] [Related]

  • 24. The immunological status of newly diagnosed tuberculosis patients co-infected with human immunodeficiency virus-1 in Adama Hospital, Ethiopia.
    Ligidi T, Gebre-Selassie S, Tsegaye A.
    Ethiop Med J; 2011 Apr 15; 49(2):75-83. PubMed ID: 21796907
    [Abstract] [Full Text] [Related]

  • 25. Mortality associated with HIV-1, HIV-2, and HTLV-I single and dual infections in a middle-aged and older population in Guinea-Bissau.
    Holmgren B, da Silva Z, Vastrup P, Larsen O, Andersson S, Ravn H, Aaby P.
    Retrovirology; 2007 Nov 27; 4():85. PubMed ID: 18042276
    [Abstract] [Full Text] [Related]

  • 26. High mortality and severe immunosuppression in hospitalized patients with pulmonary tuberculosis and HIV-2 infection in Guinea-Bissau.
    Norrgren H, Bamba S, da Silva ZJ, Andersson S, Koivula T, Biberfeld G.
    Scand J Infect Dis; 2001 Nov 27; 33(6):450-6. PubMed ID: 11450865
    [Abstract] [Full Text] [Related]

  • 27. Impact of a public antiretroviral program on TB/HIV mortality: Banteay Meanchey, Cambodia.
    Eng B, Cain KP, Nong K, Chhum V, Sin E, Roeun S, Kim S, Keo S, Heller TA, Varma JK.
    Southeast Asian J Trop Med Public Health; 2009 Jan 27; 40(1):89-92. PubMed ID: 19323039
    [Abstract] [Full Text] [Related]

  • 28. HIV-1, HIV-2, HTLV-I/II and Treponema pallidum infections: incidence, prevalence, and HIV-2-associated mortality in an occupational cohort in Guinea-Bissau.
    Norrgren H, Andersson S, Nauclér A, Dias F, Johansson I, Biberfeld G.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Aug 01; 9(4):422-8. PubMed ID: 7600111
    [Abstract] [Full Text] [Related]

  • 29. Influence of human T cell lymphotropic virus type 2 coinfection on virological and immunological parameters in HIV type 1-infected patients.
    Bassani S, López M, Toro C, Jiménez V, Sempere JM, Soriano V, Benito JM.
    Clin Infect Dis; 2007 Jan 01; 44(1):105-10. PubMed ID: 17143825
    [Abstract] [Full Text] [Related]

  • 30. Prevalence of antibodies to human T-lymphotropic virus type 1 (HTLV-1) in an HIV-endemic region of Africa.
    Maselle SY, Shao JF, Haukenes G.
    East Afr Med J; 1990 Jul 01; 67(7):461-5. PubMed ID: 2226224
    [Abstract] [Full Text] [Related]

  • 31. Human immunodeficiency virus-1 RNA levels and CD4 lymphocyte counts, during treatment for active tuberculosis, in South African patients.
    Morris L, Martin DJ, Bredell H, Nyoka SN, Sacks L, Pendle S, Page-Shipp L, Karp CL, Sterling TR, Quinn TC, Chaisson RE.
    J Infect Dis; 2003 Jun 15; 187(12):1967-71. PubMed ID: 12792875
    [Abstract] [Full Text] [Related]

  • 32. Therapeutic response of HIV-1 subtype C in African patients coinfected with either Mycobacterium tuberculosis or human herpesvirus-8.
    Cassol E, Page T, Mosam A, Friedland G, Jack C, Lalloo U, Kopetka J, Patterson B, Esterhuizen T, Coovadia HM.
    J Infect Dis; 2005 Feb 01; 191(3):324-32. PubMed ID: 15633090
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Activation of beta-chemokines and CCR5 in persons infected with human immunodeficiency virus type 1 and tuberculosis.
    Mayanja-Kizza H, Wajja A, Wu M, Peters P, Nalugwa G, Mubiru F, Aung H, Vanham G, Hirsch C, Whalen C, Ellner J, Toossi Z.
    J Infect Dis; 2001 Jun 15; 183(12):1801-4. PubMed ID: 11372034
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Increased prevalence of HTLV-1 in patients with pulmonary tuberculosis coinfected with HIV, but not in HIV-negative patients with tuberculosis.
    Norrgren HR, Bamba S, Larsen O, Da Silva Z, Aaby P, Koivula T, Andersson S.
    J Acquir Immune Defic Syndr; 2008 Aug 15; 48(5):607-10. PubMed ID: 18645510
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Tuberculosis among HIV-positive patients across Europe: changes over time and risk factors.
    Kruk A, Bannister W, Podlekareva DN, Chentsova NP, Rakhmanova AG, Horban A, Domingo P, Mocroft A, Lundgren JD, Kirk O, EuroSIDA study group.
    AIDS; 2011 Jul 31; 25(12):1505-13. PubMed ID: 21610489
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.